Navigation Links
Novel protein may help detect Lou Gehrig's disease and dementia, Mayo Clinic finds
Date:2/12/2013

onal death and toxicity in these diseases, it may be possible to design therapies to break the clumps apart or to prevent the protein from accumulating in the first place, Dr. Petrucelli says.

Because the protein is found throughout the central nervous system in patients with ALS and frontotemporal dementia but not in other neurodegenerative diseases the researchers hope that in the future it can be tested through a spinal tap.

After Alzheimer's disease, frontotemporal dementia is the most common form of early onset neurodegenerative dementia. It is characterized by changes in personality, behavior and language due to loss of gray matter in the brain's frontal lobe. ALS destroys motor neuron cells that control essential muscle activity such as speaking, walking, breathing and swallowing.

This new discovery stems from a key finding, reported simultaneously in 2011 by Mayo researchers and scientists from the National Institutes of Health, that an unusual mutation a short DNA sequence repeated hundreds to thousands of times was found in almost 12 percent of familial frontotemporal dementia and more than 22 percent of familial ALS samples studied.


'/>"/>
Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel radiation therapy method shortens prostate cancer treatment time
2. Novel gene-searching software improves accuracy in disease studies
3. New Novel Looks at British NHS from the Inside
4. Fox Chase researchers discover novel role of the NEDD9 gene in early stages of breast cancer
5. IRSF awards $1.5 million for novel basic and translational research programs
6. Nobel laureate James Watson publishes novel hypothesis on curing late-stage cancers
7. PolyU Researchers Develop Novel Treatment for People with Hemiplegic Arms
8. 2 novel treatments for retinitis pigmentosa move closer to clinical trials
9. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
10. Novel test identifies patients most likely to benefit from ALK inhibition therapy
11. Novel drug therapy targets aggressive form of non-Hodgkins lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 (HealthDay News) -- Regularly checking the pulse ... researchers report. "Screening pulse is the method of ... age 65 who have never had a stroke. Our ... and easy way to identify people who might need ... study author Dr. Bernd Kallmunzer, of Erlangen University in ...
(Date:7/23/2014)... National Institute of Biomedical Imaging and Bioengineering will host ... July 30, 2014 on the NIH campus. There will ... a wide breadth of NIBIB-funded research. , ... Engineering Microbial Rhodopsins as Optical Voltage Sensor, Quyen ... Probes for Nerve Imaging during Surgery, ...
(Date:7/23/2014)... Los Angeles, CA (PRWEB) July 23, 2014 ... physician practices delivering Enhanced External Counterpulsation (EECP), ... patient who receives EECP therapy at the health center. ... and ischemic heart disease. Since receiving ongoing EECP therapy ... , When Sara Soulati, CEO of Global Cardio ...
(Date:7/23/2014)... RIVERSIDE, Calif. Fragile X syndrome ( FXS ) ... behaviors, and other behaviors on the autistic spectrum, as ... inherited cause of mental impairment and the most common ... University of California, Riverside have published a study ... behaviors in FXS. Appearing online today (July 23) in ...
(Date:7/23/2014)... PA (PRWEB) July 23, 2014 Four ... have been lauded in the latest ranking of the ... Report . Released online today and slated for ... Guide recognizes Allegheny General Hospital (AGH), Forbes Hospital, Saint ... medical centers across multiple clinical specialties. , ...
Breaking Medicine News(10 mins):Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3
... Va., April 16 Since the inaugural National ... than one million advance directive forms have been ... Organization,s Caring Connections program. Today, the 2nd Annual ... age or current health are reminded of the ...
... #H1/F38 - Varian Medical Systems, Inc. (NYSE: VAR ... digital X-ray image detectors will exhibit its line of PaxScan ... the China International Medical Equipment Fair (CMEF) meeting in Shenzhen, ... showcase its full range of X-ray tubes for fluoroscopy, angiography, ...
... For His Discoveries About Attention And Memory, ... 16 NeuroFocus, the world leader in ... application of brainwave-based measurements for market research ... named a Partner in the company,s Consulting ...
... BLOOMINGTON, Minn., April 16 Pearson VUE, the ... it has signed an exclusive agreement with the ... be the exclusive test delivery provider of the ... CCMA examinations are delivered throughout the secure Pearson ...
... Chance to Look Like a Star with Milk on ... Only at bodybymilk.comWASHINGTON , April 16 Warding ... superheroes like Wolverine need a little help. (Photo: ... to rebuild his body far faster than any ordinary ...
... the disease, not the symptoms)HUDSON, Fla., April 16 Workforce Prescriptions ("WRX") announced on ... their unique labor waste derived from 7 sources: , , ... Agency utilization , Other "Premium Pay" ... avoidable days , Process labor waste , ...
Cached Medicine News:Health News:2nd Annual National Healthcare Decisions Day Builds on Growing Awareness of Advance Care Planning 2Health News:Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, and X-Ray Tubes at the CMEF Show in Shenzhen, China 2Health News:NeuroFocus Appoints Dr. Michael Smith as Partner in Consulting Practice 2Health News:California Certifying Board for Medical Assistants Signs Exclusive Contract with Pearson VUE 2Health News:X-Men's Wolverine Depends on Milk as His X-factor 2Health News:WRX Launches Hospital Labor Waste Calculator 2Health News:WRX Launches Hospital Labor Waste Calculator 3
(Date:7/23/2014)... 23, 2014 Research and Markets ... Gloves (Exam and Surgical) Markets Worldwide 2014" report ... The purpose of this report is ... Medical (Exam and Surgical) Gloves. The report discusses key ... products. Topics covered include product definitions, strategies, ...
(Date:7/23/2014)... , July 23, 2014  Lightlake Therapeutics Inc. ... treatments based on its expertise in opioid antagonists, ... new drug application ("IND") with respect to its ... announced today that it has received an additional ... ("NIDA"), part of the National Institutes of Health ...
(Date:7/23/2014)... , July 23, 2014 This September leading ... Las Vegas for DOCtalk ... educator, author, forward thinker and private practitioner Dr. ... together to candidly discuss clinical and practice management efficiency ... is a unique opportunity to welcome fresh thinking and ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 32014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... Therapeutics,today announced the presentation of data on the ... American Transplant,meeting to be held in San Francisco, ... with scientists at the University of,Western Ontario., "These ... extend graft,survival in transplantation, and that it can ...
... at Least 75 Percent Improvement in Psoriasis,Signs and ... Dosing Groups, More,Than Half Achieved 90 Percent Improvement, ... New,Phase II study results show Abbott's investigational treatment,ABT-874, ... treated. At 12 weeks, nine out of 10 ...
Cached Medicine Technology:Argos Therapeutics Presents Immunosuppression Data for Soluble CD83,at the American Society of Transplantation Congress 2007 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 2Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 3Abbott's Investigational Treatment ABT-874 Shows Positive Results,in Phase II Psoriasis Study 4
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Barraquer straight tying forceps....
Round handle curved tying forceps with 5 mm titanium coated platforms. Length 110 mm....
Colibri tying forceps with 5 mm titanium coated platforms. Length 85 mm....
Medicine Products: